While some heterogeneity can arise from having multiple mutations in the tumor, EGFR driver mutations are considered as an early event in tumor evolution26,27, and mutational mosaicism is rarely detected in patient tissues28–30. The gene discussed is EGFR; the disease is neoplasm.